Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-42.92%
-52.22%
-148.31%
288.19%
80.31%
46.88%
ROA
-39.56%
-45.83%
-94.41%
-147.07%
-147.63%
-143.8%
Gross Margin
100%
100%
100%
100%
100%
100%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Total Assets
SEK 1,218,637.00K
SEK 761,068.40K
SEK 396,842.25K
SEK 449,677.42K
SEK 508,941.47K
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Vicore Pharma Holding AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
SEK 542,729.59K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 477,474.00K
-SEK 453,607.76K
-SEK 546,607.09K
-SEK 622,498.60K
-SEK 707,623.00K
-SEK 756,145.73K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 3,182,582.95K
SEK 3,023,503.50K
SEK 3,643,386.67K
SEK 4,149,238.36K
SEK 4,716,631.46K
SEK 5,040,057.70K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 11.30
SEK 10.74
SEK 12.94
SEK 14.73
SEK 16.75
SEK 17.90
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Vicore Pharma Holding AB (publ) (VICO.ST) Financial Forecast | Equlion
